Skip to main content
Premium Trial:

Request an Annual Quote

Asuragen Lab Gains CAP Accreditation

NEW YORK (GenomeWeb News) – Diagnostics developer Asuragen said today that is has received accreditation as a CLIA-compliant lab by the College of American Pathologists (CAP).

The Austin, Texas-based firm said that the CAP accreditation is "a crucial step" in its plans to begin commercializing its miRNA-based oncology and clinical sample testing services.

"This is a significant step forward in our efforts to bring novel molecular diagnostic tests for oncology to market, and to offer our pharmaceutical clients a means to develop and validate companion diagnostic tests," Asuragen CEO Matt Winkler said in a statement.

The company currently is preparing its miRNA Pancreatic FFPE Test for diagnosing pancreatic adenocarcinoma.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more